A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : FACT-An / Functional Assessment of Cancer Therapy-Anemia

[Related PubMed/MEDLINE]
Total Number of Papers: 45
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   FACT-An  (>> Co-occurring Abbreviation)
Long Form:   Functional Assessment of Cancer Therapy-Anemia
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Content validity of patient-reported outcomes for use in lower-risk myelodysplastic syndromes. CD, CE, HRQoL, MDS, PROs, QUALMS
2019 Fatigue, symptom burden, and health-related quality of life in patients with myelodysplastic syndrome, aplastic anemia, and paroxysmal nocturnal hemoglobinuria. AA, MDS, PNH, QOL
2019 Validation of a patient-reported outcomes symptom measure for patients with nontransfusion-dependent thalassemia (NTDT-PRO ). NTDT, NTDT-PRO, PRO, SOB
2018 Measurement properties of the Short Form-36 (SF-36) and the Functional Assessment of Cancer Therapy - Anemia (FACT-An) in patients with anemia associated with chronic kidney disease. CKD, Hb, ICCs, SF-36
2017 A retrospective open-label uncontrolled study of Epoetin zeta on the treatment of chemotherapy-induced anemia in solid tumors. CIA, ECOG, PS
2017 Does access to clinical study reports from the European Medicines Agency reduce reporting biases? A systematic review and meta-analysis of randomized controlled trials on the effect of erythropoiesis-stimulating agents in cancer patients. CI, CSRs, EMA, ESAs, FACT-An Total, MD, QOL, RCTs
2017 Ibrutinib for patients with rituximab-refractory Waldenstrom's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial. EQ-5D-5L
2016 Impact of resistance and aerobic exercise on sarcopenia and dynapenia in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. AET, BC, CI, LE, MD, QOL, RET, SMI, UC, UE
2016 Iron Deficiency Anemia Coexists with Cancer Related Anemia and Adversely Impacts Quality of Life. CRA, IDA, QOL
10  2016 Prospective international validation of the Quality of Life in Myelodysplasia Scale (QUALMS). MDS, QUALMS, SD
11  2015 Self-perception of symptoms of anemia and fatigue before and after blood transfusions in patients with myelodysplastic syndromes. MDS
12  2014 A randomised single-blind study to improve health-related quality of life by treating anaemia of chronic kidney disease with Aranesp (darbepoetin alfa) in older people: STIMULATE. CKD, Hb, HRQoL, SF-36
13  2014 Biosimilar epoetin in elderly patients with low-risk myelodysplastic syndromes improves anemia, quality of life, and brain function. AML, ER, ESAs, Hb, MDS, MMSE, QOL
14  2013 Anemia affects the quality of life of Japanese cancer patients. ECOG-PS, Hb, QOL
15  2013 Health-related quality of life outcomes of lenalidomide in transfusion-dependent patients with Low- or Intermediate-1-risk myelodysplastic syndromes with a chromosome 5q deletion: results from a randomized clinical trial. HRQL
16  2012 Fatigue in patients with lung cancer is related with accelerated tryptophan breakdown. MAC
17  2010 Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy. RBC
18  2010 Epoetin alfa improves anemia and anemia-related, patient-reported outcomes in patients with breast cancer receiving myelotoxic chemotherapy: results of a European, multicenter, randomized, controlled trial. BSC, CLAS, ECOG PS, PROs
19  2009 Effects of epoetin-alpha on quality of life of cancer patients with solid tumors receiving chemotherapy. QOL, RBC
20  2009 L-carnitine supplementation in patients with advanced cancer and carnitine deficiency: a double-blind, placebo-controlled study. ITT, KPS, LASA, MMSE
21  2009 Weekly administration of epoetin beta for chemotherapy-induced anemia in cancer patients: results of a multicenter, Phase III, randomized, double-blind, placebo-controlled study. CIA, EPO, FSS, PD, QOL, RBC
22  2008 Common troublesome symptoms and their impact on quality of life in patients with myelodysplastic syndromes (MDS): results of a large internet-based survey. BFI, MDS, QOL
23  2008 Weekly epoetin beta maintains haemoglobin levels and improves quality of life in patients with non-myeloid malignancies receiving chemotherapy. FSS, QOL
24  2007 Clinical validity of the Japanese version of the Functional Assessment of Cancer Therapy-Anemia Scale. FACT TOI-An
25  2007 Quality of life as a predictor of weight loss in obese, early-stage breast cancer survivors. QOL
26  2006 Clinical benefits of once-weekly epoetin alfa in anemic patients with colorectal cancer receiving chemotherapy. Hgb, LASA, QOL
27  2006 Early Intervention with epoetin alfa during platinum-based chemotherapy: an analysis of quality-of-life results of a multicenter, randomized, controlled trial compared with population normative data. BSC, CLAS, Hb, QOL
28  2006 Every-three-week administration of darbepoetin alfa in women with chemotherapy-associated anemia. ---
29  2006 Once-weekly epoetin-beta improves hemoglobin levels in cancer patients with chemotherapy-induced anemia: A randomized, double-blind, dose-finding study. QOL
30  2006 Quality-of-life and health benefits of early treatment of mild anemia: a randomized trial of epoetin alfa in patients receiving chemotherapy for hematologic malignancies. QOL
31  2005 Associations among exercise, body weight, and quality of life in a population-based sample of endometrial cancer survivors. BMI, QOL
32  2005 Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy. QOL
33  2005 Impact of a new dosing regimen of epoetin alfa on quality of life and anemia in patients with low-risk myelodysplastic syndrome. Hb, MDS, QOL
34  2005 Once-weekly dose of epoetinum alfa in cancer patients with anemia receiving radiotherapy. CLAS, EPO, Hb, QOL, RT
35  2004 Cross-cultural validation of the Japanese Functional Assessment of Cancer Therapy-Anemia (FACT-An). ECOG-PSR, FACIT
36  2004 Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes: a randomized, controlled trial. Hb, MDS, rHuEPO, rHuG-CSF
37  2004 Quality of life and brain function following high-dose recombinant human erythropoietin in low-risk myelodysplastic syndromes: a preliminary report. CBF, MDS, qEEG, QOL, rHuEPO, TCD
38  2004 Weekly administration of epoetin alfa improves cognition and quality of life in patients with breast cancer receiving chemotherapy. HUI3, SOC
39  2003 Epoetin alfa treatment results in clinically significant improvements in quality of life in anemic cancer patients when referenced to the general population. QOL
40  2003 Evaluation of quality of life in a clinical trial with nonrandom dropout: the effect of epoetin alfa in anemic cancer patients. CLAS, FACT-G, MAR, MNAR, QOL, SF-36
41  2002 Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. CIDs, FACT
42  2002 Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy. LASA, QOL
43  2001 I get tired for no reason: a single item screening for cancer-related fatigue. FSI, ZSDS
44  1997 Linking outcomes management to quality-of-life measurement. FACIT, QOL
45  1997 The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue. ECOG, FACT-G, Hb, QOL